ストックスクリーナーアプリを入手
166.63
0.54%
-0.90
アフターアワーズ：
165.61
-1.02
-0.61%
Ptc Inc (PTC) 最新ニュース
How Is PTC Inc.'s Stock Performance Compared To Other Software Stocks? - Barchart.com
PTCT Investors Have Opportunity to Join PTC Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - marketscreener.com
(PTC) Proactive Strategies - news.stocktradersdaily.com
Reflecting On Design Software Stocks’ Q1 Earnings: PTC (NASDAQ:PTC) - Yahoo Finance
GAMMA Investing LLC Increases Stake in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Pallas Capital Advisors LLC Purchases New Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC ... - Bluefield Daily Telegraph
PTC Brings Cloud-Native Model-Based Definition to Onshape - MSN
Harbor Capital Advisors Inc. Has $2.08 Million Stock Holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
PTC: Margin Strength Meets Valuation Reset - Seeking Alpha
Oppenheimer Boosts PTC Price Target to $190, Reaffirms Outperfor - GuruFocus
PTC Unveils Onshape's Next-Generation Model-Based Definition Cap - GuruFocus
Oppenheimer Raises Price Target for PTC Amid Market Optimism | P - GuruFocus
PTC (NasdaqGS:PTC) Unveils Cloud-Native MBD Innovation in Onshape Platform - Yahoo Finance
PTC Inc. Unveils Onshape's Next-Generation Model-Based Definition Capabilities with Aura Aero At Paris Air Show - marketscreener.com
PTC Revolutionizes CAD Industry with First Cloud-Native Model-Based Definition Platform - Stock Titan
Oppenheimer Adjusts Price Target on PTC to $190 From $170 - marketscreener.com
PTC Revamps Go-To-Market Approach But Client Decisions Slow (NASDAQ:PTC) - Seeking Alpha
Transcript : PTC Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 09 - marketscreener.com
Wealth Enhancement Advisory Services LLC Sells 479 Shares of PTC Inc. (NASDAQ:PTC) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against PTC Therapeutics, Inc. (PTCT) And Encourages Shareholders to Reach Out - ACCESS Newswire
Why PTC Inc. (PTC) is a Top Value Stock for the Long-Term - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Purchases Shares of 108,345 PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
PTC Launches Creo 12 to Accelerate Design Speed, Productivity, and Collaboration - StreetInsider
PTC Launches Creo 12 CAD Software - Digital Engineering 24/7
Mackenzie Financial Corp Acquires 12,967 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
3 Things Nvidia Management Just Said That Build the Buy Case for These 3 Magnificent Hidden AI Stocks - The Motley Fool
(PTC) Investment Analysis - news.stocktradersdaily.com
Transcript : PTC Inc. Presents at Baird Global Consumer, Technology & Services Conference 2025, Jun-03-2025 02 - marketscreener.com
PTC shares tumble as guidance falls short of expectations By Investing.com - Investing.com Nigeria
PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $63.75 Consensus PT from Brokerages - MarketBeat
Quantinno Capital Management LP Invests $436,000 in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Why Is PTC Inc. (PTC) Up 7.4% Since Last Earnings Report? - Yahoo Finance
With PTC Inc. (NASDAQ:PTC) It Looks Like You'll Get What You Pay For - simplywall.st
BNP Paribas Financial Markets Has $465,000 Stake in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
Millennium Management LLC Has $13.97 Million Position in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT) Shares Sold by Bank of America Corp DE - MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT) Stock Holdings Lifted by ProShare Advisors LLC - MarketBeat
PTC’s SWOT analysis: stock outlook amid GTM shift and ARR growth - Investing.com Australia
Interesting PTC Put And Call Options For February 2026 - Nasdaq
PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
State of Wyoming Makes New Investment in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc.PTCT - PR Newswire
1.46%
大文字化:
|
ボリューム (24 時間):